Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the end TB era. Lancet Respir Med. 2018;6(4):299–314.
Article
Google Scholar
World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization; 2018.
Alvarez-Uria G, Naik PK, Pakam R, Midde M. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action. 2013;6(1):21682.
Article
Google Scholar
Mutasa-Apollo T, Shiraishi RW, Takarinda KC, Dzangare J, Mugurungi O, Murungu J, Abdul-Quader A, Woodfill CJ. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010. PLoS One. 2014;9(1):e86305.
Article
Google Scholar
Alvarez-Uria G, Midde M, Pakam R, Naik PK. Predictors of attrition in patients ineligible for antiretroviral therapy after being diagnosed with HIV: data from an HIV cohort study in India. Biomed Res Int. 2013;2013.
Massavon W, Lundin R, Costenaro P, Penazzato M, Namisi PC, Ingabire R, Giaquinto C. Attrition and loss to follow-up among children and adolescents in a community home-based care HIV programme in Uganda. Pediat Therapeut. 2013;3(183):2161–0665.
Google Scholar
Weiler G. Global update on HIV treatment 2013: results, impact and opportunities, vol. 14. Geneva: World Health Organization; 2013. p. 2017.
Google Scholar
Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30(Supplement 1):S5–14.
Article
Google Scholar
Low-Beer S, Yip B, O'shaughnessy MV, Hogg RS, Montaner JS. Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr. 2000;23(4):360–1.
Article
CAS
Google Scholar
Taiwo B. Understanding transmitted HIV resistance through the experience in the USA. Int J Infect Dis. 2009;13(5):552–9.
Article
Google Scholar
Dalal RP, MacPhail C, Mqhayi M, Wing J, Feldman C, Chersich MF, Venter WD. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;47(1):101–7.
PubMed
Google Scholar
Bygrave H, Kranzer K, Hilderbrand K, Whittall J, Jouquet G, Goemaere E, Vlahakis N, Triviño L, Makakole L, Ford N. Trends in loss to follow-up among migrant workers on antiretroviral therapy in a community cohort in Lesotho. PLoS One. 2010;5(10):e13198.
Article
Google Scholar
Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009;4(6):e579.
Article
Google Scholar
Fatti G, Meintjes G, Shea J, Eley B, Grimwood A. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. J Acquir Immune Defic Syndr. 2012;61(4):e50–8.
Article
Google Scholar
Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, Coutinho A, Jaffar S. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009;9(1):290.
Article
Google Scholar
Lanoy E, Mary-Krause M, Tattevin P, Dray-Spira R, Duvivier C, Fischer P, Obadia Y, Lert F, Costagliola D. Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol. 2006;59(8):829–35.
Article
Google Scholar
Shaweno D, Worku A. Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in southern Ethiopia: a retrospective cohort study. BMC Res Notes. 2012;5(1):682.
Article
Google Scholar
Schöni-Affolter F, Keiser O, Mwango A, Stringer J, Ledergerber B, Mulenga L, Bucher HC, Westfall AO, Calmy A, Boulle A, Chintu N. Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland. PLoS One. 2011;6(12):e27919.
Article
Google Scholar
Assefa Y, Kiflie A, Tesfaye D, Mariam DH, Kloos H, Edwin W, Laga M, Van Damme W. Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities. BMC Health Serv Res. 2011;11(1):81.
Article
Google Scholar
Ababa A. Ethiopia and ICF International Calverton. Maryland. 2012;2012.
Tadesse K, Fisiha H. Predictors of loss to follow up of patients enrolled on antiretroviral therapy: a retrospective cohort study. J AIDS Clin Res. 2014;5(393):2.
Google Scholar
Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, Fox MP, MacPhail P, van Cutsem G, Messou E, Wood R, Nash D. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Med. 2011;8(1):e1000390.
Article
Google Scholar
Tran DA, Ngo AD, Shakeshaft A, Wilson DP, Doran C, Zhang L. Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: findings from 13 outpatient clinics. PLoS One. 2013;8(9):e73181.
Article
CAS
Google Scholar
Agbor AA, Bigna JJ, Billong SC, Tejiokem MC, Ekali GL, Plottel CS, Noubiap JJ, Abessolo H, Toby R, Koulla-Shiro S. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé central hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006–2013). PLoS One. 2014;9(12):e115211.
Article
Google Scholar
Mutembo S, Mutanga JN, Musokotwane K, Alisheke L, Whalen CC. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm 3. BMC Infect Dis. 2016;16(1):572.
Article
Google Scholar
Yende-Zuma N, Naidoo K. The effect of timing of initiation of ART on loss to follow up in HIV-TB co infected patients in South Africa: an open label randomized controlled trial. J Acquir Immune Defic Syndr (1999). 2016;72(4):430.
Article
CAS
Google Scholar
Matsumoto S, Tanuma J, Mizushima D, Nguyen NC, Pham TT, Do CD, Nguyen TQ, Nguyen DT, Nguyen HD, Nguyen LT, Van Nguyen K. High treatment retention rate in HIV-infected patients receiving antiretroviral therapy at two large HIV clinics in Hanoi, Vietnam. PLoS One. 2015;10(9):e0139594.
Article
Google Scholar
Rogers JH, Jabateh L, Beste J, Wagenaar BH, McBain R, Palazuelos D, Wickett E, Oswald C, Napier HG, Toomey-Garbo J. Impact of community-based adherence support on treatment outcomes for tuberculosis, leprosy and HIV/AIDS-infected individuals in post-Ebola Liberia. Glob Health Action. 2018;11(1):1522150.
Article
Google Scholar
Telele NF, Kalu AW, Marrone G, Gebre-Selassie S, Fekade D, Tegbaru B, Sönnerborg A. Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia. PLoS One. 2018 Jul 11;13(7):e0200505.
Article
Google Scholar
Thida A, Tun ST, Zaw SK, Lover AA, Cavailler P, Chunn J, Aye MM, Par P, Naing KW, Zan KN, Shwe M. Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis. PLoS One. 2014;9(9):e108615.
Article
Google Scholar
Dessalegn M, Tsadik M, Lemma H. Predictors of lost to follow up to antiretroviral therapy in primary public hospital of Wukro, Tigray, Ethiopia: a case control study. J AIDS HIV Res. 2015;7(1):1–9.
Article
Google Scholar
Berheto TM, Haile DB, Mohammed S. Predictors of loss to follow-up in patients living with HIV/AIDS after initiation of antiretroviral therapy. N Am J Med Sci. 2014;6(9):453.
Article
Google Scholar
Teshome W, Belayneh M, Moges M, Mekonnen E, Endrias M, Ayele S, Misganaw T, Shiferaw M, Tesema T. Do loss to follow-up and death rates from ART care vary across primary health care facilities and hospitals in South Ethiopia? A retrospective follow-up study. HIV/AIDS (Auckl). 2015;7:167.
Google Scholar